Fjarde AP Fonden Fourth Swedish National Pension Fund Cuts Stock Position in Kenvue Inc. $KVUE

Key Points

• Fjarde AP Fonden Fourth Swedish National Pension Fund sold 97,800 shares of Kenvue Inc., reducing its stake by 20.4%, and its holdings are now valued at approximately $9.16 million.
• Kenvue declared a quarterly dividend of $0.2075, an increase from its previous dividend of $0.21, representing an annual yield of 3.9%.
• Analysts have decreased their price targets for Kenvue, with a consensus rating of "Hold" and an average target price of $24.38.

Fjarde AP Fonden Fourth Swedish National Pension Fund lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 20.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 381,832 shares of the company's stock after selling 97,800 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Kenvue were worth $9,156,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in KVUE. Rockefeller Capital Management L.P. lifted its holdings in Kenvue by 5.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 185,372 shares of the company's stock worth $3,958,000 after acquiring an additional 9,514 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new position in Kenvue in the 4th quarter worth approximately $303,000. Mariner LLC lifted its stake in shares of Kenvue by 50.7% in the 4th quarter. Mariner LLC now owns 259,420 shares of the company's stock valued at $5,538,000 after purchasing an additional 87,321 shares during the last quarter. Guggenheim Capital LLC boosted its holdings in Kenvue by 13.3% during the fourth quarter. Guggenheim Capital LLC now owns 196,128 shares of the company's stock valued at $4,187,000 after acquiring an additional 22,986 shares during the period. Finally, NewEdge Advisors LLC increased its stake in Kenvue by 14.1% in the fourth quarter. NewEdge Advisors LLC now owns 37,489 shares of the company's stock valued at $800,000 after acquiring an additional 4,637 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on KVUE. Bank of America cut their target price on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Tuesday, July 15th. Canaccord Genuity Group dropped their price objective on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Barclays dropped their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, July 15th. Zacks Research raised shares of Kenvue to a "strong sell" rating in a report on Monday, August 11th. Finally, Citigroup reduced their price objective on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 15th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Kenvue currently has an average rating of "Hold" and an average target price of $24.38.

Kenvue Stock Performance

Shares of NYSE KVUE traded up $0.2970 during midday trading on Tuesday, hitting $21.3970. 5,798,435 shares of the company's stock traded hands, compared to its average volume of 17,494,551. The firm has a fifty day moving average of $21.54 and a 200 day moving average of $22.43. The stock has a market capitalization of $41.06 billion, a price-to-earnings ratio of 28.91, a price-to-earnings-growth ratio of 3.05 and a beta of 0.83. Kenvue Inc. has a 1 year low of $19.75 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the company earned $0.32 earnings per share. Kenvue's revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th will be issued a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, August 13th. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 3.9%. Kenvue's dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.